Ji-Won Kim

Has grant

Assistant professor

Catholic University of Korea School of Medicine

South Korea

Research Interests

Explore related searches

Professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Ji-Won Kim is an Assistant Professor at Daegu Catholic University School of Medicine in South Korea. His research focuses on the mechanisms of inflammation and cardiovascular risk in patients with rheumatoid arthritis, as well as the therapeutic effects of various medications on autoimmune inflammatory diseases. Recent articles include studies on interleukin-37, various statins, and other pharmacological interventions aimed at managing rheumatoid arthritis and related complications.

Recent Grants

Grant: Close

2019R1G1A1100421

Open Date:

Close Date:

Grant: Close

2022R1F1A1073837

Open Date:

Close Date:

Articles (14)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (5)

Eun Ha Kang

Seoul National University Hospital

SOUTH KOREA

View details

Sung-Hwan Park

SOUTH KOREA

View details

Eun Jin Kim

Catholic University of Korea School of Medicine

SOUTH KOREA

View details

Sung-Hoon Park

Associate professor

Catholic University of Korea School of Medicine

SOUTH KOREA

View details

Seong-Kyu Kim

Catholic University of Korea School of Medicine

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ji-Won Kim

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (14)

Interleukin-37 Inhibits Interleukin-1β-Induced Articular Chondrocyte Apoptosis by Suppressing Reactive Oxygen Species

Anti-Inflammatory Effect of Atorvastatin and Rosuvastatin on Monosodium Urate-Induced Inflammation through IL-37/Smad3-Complex Activation in an In Vitro Study Using THP-1 Macrophages

HMG-CoA Reductase Inhibitors Suppress Monosodium Urate-Induced NLRP3 Inflammasome Activation through Peroxisome Proliferator-Activated Receptor-γ Activation in THP-1 Cells

Histone Deacetylase 6 Inhibitor CKD-WID Suppressed Monosodium Urate-Induced Osteoclast Formation by Blocking Calcineurin-NFAT Pathway in RAW 264.7 Cells

Performance of Cardiovascular Risk Prediction Models in Korean Patients With New-Onset Rheumatoid Arthritis: National Cohort Study.

Cardiovascular risk of Janus kinase inhibitors compared with biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis without underlying cardiovascular diseases: a nationwide cohort study.

Methotrexate, leflunomide, and tacrolimus use and the progression of rheumatoid arthritis-associated interstitial lung disease.

Differential effects of periodontal microbiome on the rheumatoid factor induction during rheumatoid arthritis pathogenesis.

Impact of a pharmaceutical care service for patients with rheumatoid arthritis using a customised mobile device (the PROUD trial): study protocol for a randomised controlled trial.

Metformin and its therapeutic applications in autoimmune inflammatory rheumatic disease.

Therapeutic Potential of a Novel <i>Bifidobacterium</i> Identified Through Microbiome Profiling of RA Patients With Different RF Levels.

Prognostic Implication of Baseline Sarcopenia for Length of Hospital Stay and Survival in Patients With Coronavirus Disease 2019.

The beneficial effect of baricitinib on ultrasound-detected synovial inflammation and bone damage in rheumatoid arthritis: Preliminarily data from single center-based observational study for 24 weeks.

Baseline use of hydroxychloroquine or immunosuppressive drugs and the risk of coronavirus disease 2019.

Collaborators (5)

Eun Ha Kang

Sung-Hwan Park

Eun Jin Kim

Sung-Hoon Park

Seong-Kyu Kim

Make your next move.